Literature DB >> 17653133

Determination of dimethylarginine dimethylaminohydrolase activity in the kidney.

Y-L Tain1, C Baylis.   

Abstract

Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethylarginine to generate L-citrulline and is present in large quantities in the kidney. We present a new study that optimizes the Prescott-Jones colorimetric assay to measure DDAH-dependent L-citrulline generation in kidney homogenates. We found that the removal of urea with urease is necessary since urea also produces a positive reaction. Deproteinization with sulfosalicylic acid was found to be optimal and that protease inhibitors were not necessary. All assays were conducted in phosphate buffer, since other common additives can create false positive and false negative reactions. Arginase or nitric oxide synthase isoenzymes were not found to influence L-citrulline production. Our optimized L-citrulline production assay to measure DDAH activity correlated closely with the direct measure of the rate of asymmetric dimethylarginine consumption. Using this assay, we found that both superoxide and nitric oxide inhibit renal cortical DDAH activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653133      PMCID: PMC2756814          DOI: 10.1038/sj.ki.5002446

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  MODIFIED DETERMINATION OF ORNITHINE-CARBAMYL-TRANSFERASE ACTIVITY IN BIOLOGICAL MATERIAL.

Authors:  V KULHANEK; V MADEROVA; K SINDELAROVA; V VOJTISKOVA
Journal:  Clin Chim Acta       Date:  1963-07       Impact factor: 3.786

2.  Biosynthesis of urea. IV. Further studies on condensation in arginine synthesis from citrulline.

Authors:  S RATNER; B PETRACK
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

3.  A colorimetric method for the determination of citrulline.

Authors:  A G Gornall; A Hunter
Journal:  Biochem J       Date:  1941-06       Impact factor: 3.857

4.  Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat.

Authors:  You-Lin Tain; Gary Freshour; Anna Dikalova; Kathy Griendling; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-02

Review 5.  Almost all about citrulline in mammals.

Authors:  E Curis; I Nicolis; C Moinard; S Osowska; N Zerrouk; S Bénazeth; L Cynober
Journal:  Amino Acids       Date:  2005-08-08       Impact factor: 3.520

6.  Modified methods for the determination of carbamyl aspartate.

Authors:  L M Prescott; M E Jones
Journal:  Anal Biochem       Date:  1969-12       Impact factor: 3.365

7.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

8.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.

Authors:  R J MacAllister; H Parry; M Kimoto; T Ogawa; R J Russell; H Hodson; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

9.  A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline.

Authors:  M Knipp; M Vasák
Journal:  Anal Biochem       Date:  2000-11-15       Impact factor: 3.365

10.  Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

Authors:  A Ito; P S Tsao; S Adimoolam; M Kimoto; T Ogawa; J P Cooke
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

View more
  27 in total

1.  MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.

Authors:  Laura G Di Pasqua; Clarissa Berardo; Vittoria Rizzo; Plinio Richelmi; Anna Cleta Croce; Mariapia Vairetti; Andrea Ferrigno
Journal:  Mol Cell Biochem       Date:  2016-06-29       Impact factor: 3.396

2.  A mini-network balance model for evaluating the progression of cardiovascular complications in Goto-Kakizaki rats.

Authors:  Hao Jiang; Yu-Hao Wang; Chun-Xiang Wei; Xue Zhang; Hao-Chen Liu; Xiao-Quan Liu
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

3.  Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Authors:  Gin-Fu Chen; Laszlo Wagner; Jennifer M Sasser; Sergey Zharikov; Natasha C Moningka; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2010-05-19       Impact factor: 5.992

4.  Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol.

Authors:  Dan Wang; Zaiming Luo; Xiaoyan Wang; Pedro A Jose; John R Falck; William J Welch; Shakil Aslam; Tom Teerlink; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-09-13       Impact factor: 10.190

5.  Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Mark W Cunningham; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-08

6.  Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells.

Authors:  Zaiming Luo; Tom Teerlink; Kathy Griendling; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

7.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

8.  In vivo renal arginine release is impaired throughout development of chronic kidney disease.

Authors:  Gin-Fu Chen; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.

Authors:  Jiang Li; Annette Wilson; Xiang Gao; Ramalinga Kuruba; Youhua Liu; Samuel Poloyac; Bruce Pitt; Wen Xie; Song Li
Journal:  J Pharmacol Exp Ther       Date:  2009-07-15       Impact factor: 4.030

10.  Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.

Authors:  Michael D Wetzel; Ting Gao; Kristen Stanley; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.